We are live on
!
Find out more
APM
Avidity Partners Management Portfolio holdings
AUM
$936M
1-Year Est. Return
195%
This Fund
S&P 500
This Quarter
Est. Return
+7.15%
1 Year Est. Return
+195%
3 Year Est. Return
+460.87%
5 Year Est. Return
+815.5%
10 Year Est. Return
–
AUM
$3.58B
AUM Growth
+$609M
(+20%)
Cap. Flow
+$630M
Cap. Flow
% of AUM
17.57%
Top 10 Holdings %
Top 10 Hldgs %
34.78%
Holding
131
New
36
Increased
33
Reduced
15
Closed
37
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
+$105M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$93.1M |
| 3 |
Medtronic
MDT
|
+$84.8M |
| 4 |
Nuvation Bio
NUVB
|
+$84.1M |
| 5 |
AbbVie
ABBV
|
+$77.1M |
Top Sells
| 1 |
Eli Lilly
LLY
|
+$137M |
| 2 |
Quest Diagnostics
DGX
|
+$94.4M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$87.1M |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$57.5M |
| 5 |
Organogenesis Holdings
ORGO
|
+$55M |
Sector Composition
| 1 | Healthcare | 96.26% |
| 2 | Financials | 0.29% |
| 3 | Industrials | 0% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
AbbVie
ABBV
$431B
| $225M | 6.27% |
2,077,200
+721,200
| +53% | +$77.1M |
|
2
AstraZeneca
AZN
$261B
| $182M | 5.06% |
1,825,250
+675,250
| +59% | +$67.9M |
|
3
Avantor
AVTR
$7.65B
| $144M | 4.02% |
4,985,100
-1,581,600
| -24% | -$45.7M |
|
|
4
Medtronic
MDT
$103B
| $121M | 3.38% |
1,024,200
+723,200
| +240% | +$84.8M |
|
5
Arvinas
ARVN
$534M
| $116M | 3.25% |
1,760,300
-27,058
| -2% | -$2.07M |
|
|
6
Intuitive Surgical
ISRG
$138B
| $103M | 2.87% |
+418,200
| New | +$105M |
|
7
Maravai LifeSciences
MRVI
$1.04B
| $98.4M | 2.75% |
2,761,545
-684,227
| -20% | -$22.7M |
|
8
Cardinal Health
CAH
$52.7B
| $88.9M | 2.48% |
1,463,000
+655,000
| +81% | +$36.2M |
|
9
Syndax Pharmaceuticals
SNDX
$2.08B
| $86M | 2.4% |
3,846,000
+538,000
| +16% | +$12.2M |
|
|
EPIX
10
DELISTED
ESSA Pharma
EPIX
| $82.5M | 2.3% |
2,840,000
+282,000
| +11% | +$6.56M |
|
|
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $81.5M | 2.27% |
475,700
+95,700
| +25% | +$18.9M |
|
|
SGEN
12
DELISTED
Seagen Inc. Common Stock
SGEN
| $80.2M | 2.24% |
+577,900
| New | +$93.1M |
|
|
EXAS
13
DELISTED
Exact Sciences
EXAS
| $78.8M | 2.2% |
598,000
+351,000
| +142% | +$48M |
|
|
14
Nuvation Bio
NUVB
$2.05B
| $78.6M | 2.19% |
+7,521,941
| New | +$84.1M |
|
|
BHVN
15
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $71.8M | 2% |
1,049,800
+558,000
| +113% | +$45.1M |
|
16
Vertex Pharmaceuticals
VRTX
$121B
| $66.8M | 1.86% |
310,900
+163,600
| +111% | +$35.9M |
|
|
NBP
17
NovaBridge Biosciences American Depositary Shares
NBP
$214M
| $64.4M | 1.8% |
1,329,000
-262,000
| -16% | -$14.2M |
|
|
ARNA
18
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $62.4M | 1.74% |
898,550
+277,550
| +45% | +$21.4M |
|
19
Alnylam Pharmaceuticals
ALNY
$37.3B
| $60.4M | 1.69% |
+427,969
| New | +$64.4M |
|
20
Bausch Health
BHC
$1.83B
| $60M | 1.67% |
1,891,300
-80,700
| -4% | -$2.37M |
|
|
CTLT
21
DELISTED
CATALENT, INC.
CTLT
| $59M | 1.65% |
560,000
+223,000
| +66% | +$24.9M |
|
22
Zentalis Pharmaceuticals
ZNTL
$340M
| $54.8M | 1.53% |
1,263,300
+128,300
| +11% | +$5.52M |
|
|
HZNP
23
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $53.5M | 1.49% |
581,000
-588,300
| -50% | -$49.6M |
|
|
BPMC
24
DELISTED
Blueprint Medicines
BPMC
| $53.1M | 1.48% |
546,000
+306,000
| +128% | +$30.6M |
|
25
Zimmer Biomet
ZBH
$17.4B
| $52.2M | 1.46% |
+335,780
| New | +$52M |
|
Similar funds
NM
LM
IF
PWAM
CM
LJAC
PO
SH